Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Shared Decision-Making (SDM) in Lung Cancer
Release Date:
|
Education | Oncology | Japan | |
Projects for Enhancing Regional Cancer Treatment
Release Date:
Partner: Japanese Society of Clinical Oncology
|
Quality Improvement | Oncology | Japan | |
Improving the Therapeutic Environment for Metastatic Breast Cancer
Release Date:
|
Education | Oncology | Japan | |
Reducing Barriers to Optimal Clinical Care in Breast Cancer
Release Date:
|
Quality Improvement | Oncology | Spain | |
2024 IM US Headache Medicine Fellowship
Release Date:
|
Fellowship | Internal Medicine | USA | |
Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
|
Education | Internal Medicine | All | |
The Value of Standardized Diagnosis and Treatment in Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Real World Evidence of Abrocitinib in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Release Date:
|
Research | Inflammation & Immunology | China | |
Bolstering Clinical Research Capacity to Address China Health Equity Disparities
Release Date:
|
Education | Health Equity | China | |
Enhancing Molecular Testing for Metastatic Colorectal Cancer Patients
Release Date:
Partner: Colorectal Cancer Canada (CCC)
|
Quality Improvement | Oncology | Canada | |
Junior Investigator Global ATTR Cardiac Amyloidosis Research
Release Date:
|
Research | Rare Disease | Australia, Canada, France, Germany, Italy, Japan, Korea, Spain |
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
Release Date:
Partner: Japanese Dermatological Association
|
Quality Improvement | Inflammation & Immunology | Japan | |
Vaccines for All: Longevity Unleashed for Everyone (VALUE)
Release Date:
|
Quality Improvement | Vaccines | Japan | |
UK Oncology Quality Improvement Grants
Release Date:
|
||||
Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
Release Date:
|
||||
Translating the Atopic Dermatitis (AD)
Release Date:
|
||||
Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
Release Date:
|
||||
Rheumatology Nurse Practitioner and Physician Assistant Fellowship
Release Date:
|
||||
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | All | |
Quality Improvement initiatives optimizing AF and VTE management in Canada
Release Date:
|
||||
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
||||
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
||||
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
Release Date:
|